Solid self nano-emulsifying system for the enhancement of dissolution and bioavailability of Prasugrel HCl: in vitro and in vivo studies

References

• Abhishek S, Anup N, Juhi P, Neha X. 2018. Phase diagrams for three component mixtures in pharmaceuticals and its applications. J Young Pharm. 10(2):132–137.
   Web of Science ®Google Scholar
• Agrawal A, Kumar A, Gide P. 2015. Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide. Colloids Surf B Biointerfaces. 126:553–560.
   PubMed Web of Science ®Google Scholar
• Al Omari MMH, Qinna NA, Rashid IS, Al-Sou’od KA, Badwan AA. 2015. Prasugrel Hydrochloride. Profiles Drug Subst Excip Relat Methodol. 40:195–320.
   PubMedGoogle Scholar
• Amit A, Patravale V. 2008. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS PharmSciTech. 9(1):191–196.
   PubMed Web of Science ®Google Scholar
• Bardhan S, Kundu K, Chakraborty G, Saha SK, Paul BK. 2015. The schulman method of cosurfactant titration of the oil/water interface (dilution method): a review on a well-known powerful technique in interfacial science for characterization of water-in-oil microemulsions. J Surfact Deterg. 18(4):547–567.
   Web of Science ®Google Scholar
• Bhupinder S, Shantanu B, Rishi K, Ramandee pS, Om Parkash K. 2009. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 26(5):427–521.
   PubMed Web of Science ®Google Scholar
• Born GV. 1962. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:927–929.
   PubMed Web of Science ®Google Scholar
• Brittain HG. 2005. Analytical profiles of drug substances and excipients. Vol. 22. Cambridge, MA: The Academic Press, Elsevier, p. 359–388.
   Google Scholar
• Brittain HG. 2015. Profiles of drug substances, excipients, and related methodology. Vol. 40. Cambridge, MA:The Academic Press, Elsevier, p. 541.
   Google Scholar
• Chhabra G, Chuttani K, Mishra A, Pathak K. 2011. Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev Ind Pharm. 37(8):907–916.
   PubMed Web of Science ®Google Scholar
• Conran N, Rees D. 2017. Prasugrel hydrochloride for the treatment of sickle cell disease. Expert Opin Investig Drugs. 26(7):865–872.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR. 2018. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 10(2):57.
   PubMed Web of Science ®Google Scholar
• Dash R, Habibuddin M, Humaira T, Atla V. 2015. Solid supersaturatable self-nanoemulsifying drug delivery systems for improved dissolution, absorption and pharmacodynamic effects of glipizide. J Drug Deliv Sci Technol. 28:28–36.
   Web of Science ®Google Scholar
• Dejana E, Callioni A, Quintana A, De Gaetano G. 1979. Bleeding time in laboratory animals. II – A comparison of different assay conditions in rats. Thromb Res. 15(1-2):191–197.
   PubMed Web of Science ®Google Scholar
• Deshmukh SR, Bakhle SS, Upadhye KP, Dixit GR. 2016. Formulation and evaluation of solid self-emulsifying drug delivery system of gliclazide. Int J Pharm Pharm Sci. 8(11):144–151.
   Google Scholar
• Dharankar SD, Parakh DR, Patil MP, Kshirsagar SJ. 2015. Spray-dried solid self-emulsifying delivery system of ketoprofen: development and its characterization. Dry Technol. 33(15-16):2002–2011.
   Web of Science ®Google Scholar
• Diaz DA, Colgan ST, Langer CS, Bandi NT, Likar MD, Van Alstine L. 2016. Dissolution similarity requirements: how similar or dissimilar are the global regulatory expectations? AAPS J. 18(1):15–22.
   PubMed Web of Science ®Google Scholar
• Guidence for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. 1997. The US Food and Drug Administration Guidance. (SUPAC–IR), Rockville, MD.
   Google Scholar
• Gupta S, Kesarla R, Omri A. 2013. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm.:848043.
   PubMedGoogle Scholar
• Heras M, Chesebro JH, Webster MW, Mruk JS, Grill DE, Penny WJ, Bowie EJ, Badimon L, Fuster V. 1990. Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. Circulation. 82(4):1476–1484.
   PubMed Web of Science ®Google Scholar
• ICH Harmonized Tripartite Guidelines. 2003. USA: ICH; https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf.
   Google Scholar
• Iswarya S, Abha D, Bhagyashri J, Vandana W, Jesal D. 2013. Solid dispersions: An approach to enhance solubility of poorly water soluble drugs. J Sci Innov Res. 2(3):685–694.
   Google Scholar
• Janupally R, Ganesh K, Saritha D, Mahesh V. 2018. Formulation and evaluation of furosemide solid self-emulsifying drug delivery system. Asian J Pharm. 12(2).
   Web of Science ®Google Scholar
• Kassem AM, Ibrahim HM, Samy AM. 2017. Development and optimisation of atorvastatin calcium loaded self-nanoemulsifying drug delivery system (SNEDDS) for enhancing oral bioavailability: in vitro and in vivo evaluation. J Microencapsul. 34(3):319–333.
   PubMed Web of Science ®Google Scholar
• Khanfar M, Al-Nimry S. 2017. Stabilization and amorphization of lovastatin using different types of silica. AAPS PharmSciTech. 18(6):2358–2367.
   PubMed Web of Science ®Google Scholar
• Kotharapu RK, Lankalapalli S. 2019. Development and evaluation of prasugrel hydrochloride floating tablets. J Drug Deliv Ther. 9(4-s):118–125.
   Google Scholar
• Lawless E, Griffin B, O'Mahony A, O'Driscoll C. 2015. Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies. Pharm Res. 32(5):1817–1829.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jennings NL, Dart AM, Du X-J. 2012. Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice. WJEM. 2(2):30–36.
   Google Scholar
• Lu N, Li L, Zheng X, Zhang S, Li Y, Yuan J, Wei Q, Xu Y, Meng F. 2018. Synthesis of a novel series of amino acid prodrugs based on thienopyridine scaffolds and evaluation of their antiplatelet activity. Molecules. 23(5):1041.
   Web of Science ®Google Scholar
• Minghui S, Luqin S, Xuezhen Z, Zhaoze F, Yiming M, Rui Z, Xiangliang Y. 2011. The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems. Drug Dev Ind Pharm. 37(8):986–994.
   PubMed Web of Science ®Google Scholar
• Nasr A, Gardouh A, Ghorab M. 2016. Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics. 8(3):20.
   PubMed Web of Science ®Google Scholar
• Nigade P, Patil S, Tiwari S. 2012. Self Emulsifying drug delivery system (SEDDS): a review. Int J Pharm Biol Sci. 2(2):42–52.
   Google Scholar
• Niitsu Y, Sugidachi A, Ogawa T, Jakubowski JA, Hashimoto M, Isobe T, Otsuguro K, Asai F. 2008. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species. Eur J Pharmacol. 579(1-3):276–282.
   PubMed Web of Science ®Google Scholar
• Raj K, Reddipogu P, Kumar S, Bathini R, Mohammad H, Jithan A. 2014. Investigation of solubility enhancement of prasugrel hydrochloride: nanosuspensions and cyclodextrin inclusion complexes. Indian Drugs. 5(102):29–38.
   Google Scholar
• Saifee M, Zarekar S, Rao V, Zaheer Z, Soni R, Burande S. 2013. Formulation and in vitro evaluation of solid- self- emulsifying drug delivery system (sedds) of glibenclamide. Am J Adv Drug Deliv. 1:323–340.
   Google Scholar
• Sandhiya J, Avtar C, Gurpreet S, Geeta A. 2012. An overview on solubility enhancement techniques for poorly soluble drugs and solid dispersion techniques for poorly soluble drugs and solid dispersion as an eminent strategic approach. Int J Pharm Sci Res. 3(4):942–956.
   Google Scholar
• Selvamani V. 2019. Chapter 15 - Stability studies on nanomaterials used in drugs. In: Mohapatra SS, Ranjan S, Dasgupta N, editors. Characterization and biology of nanomaterials for drug delivery: Nanoscience and Nanotechnology in drug delivery. Elsevier science; p. 425–444.
   Google Scholar
• Shalito I, Kopyleva O, Serebruany V. 2009. Novel antiplatelet agents in development: Prasugrel, ticagrelor, and cangrelor and beyond. Am J Ther. 16(5):451–458.
   PubMed Web of Science ®Google Scholar
• Sri B, Muzib Y. 2015. A review on sedds and solid sedds: an emerging dosage forms for poorly soluble drugs. Am J PharmTech Res. 5:30–48.
   Google Scholar
• Sri B, Muzib Y. 2015. A review on SEDDS and Solid SEDDS: an emerging dosage forms for poorly soluble drugs. Am J PharmTech Res. 5(2):2249–3387.
   Google Scholar
• Stepankova H, Kaminska K, Hajicek J. inventors. 2011. A method for the preparation of prasugrel hydrochloride in polymorphous form b. Google Patent, number WO2011069473A1.
   Google Scholar
• Sugidachi A, Asai F, Koike H. 1993. In vivo pharmacology of aprosulate, a new synthetic polyanion with anticoagulant activity. Thromb Res. 69(1):71–80.
   PubMed Web of Science ®Google Scholar
• Sugidachi A, Asai F, Ogawa T, Inoue T, Koike H. 2000. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties. Br J Pharmacol. 129(7):1439–1446.
   PubMed Web of Science ®Google Scholar
• Sugidachi A, Ogawa T, Kurihara A, Hagihara K, Jakubowski JA, Hashimoto M, Niitsu Y, Asai F. 2007. The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite. J Thromb Haemost. 5(7):1545–1551.
   PubMed Web of Science ®Google Scholar
• Sugidachi A, Ohno K, Ogawa T, Jakubowski J, Hashimoto M, Tomizawa A. 2013. A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats. Br J Pharmacol. 169(1):82–89.
   PubMed Web of Science ®Google Scholar
• Tang B, Cheng G, Gu J, Xu C. 2008. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today. 13(13-14):606–612.
   PubMed Web of Science ®Google Scholar
• Tsume Y, Mudie DM, Langguth P, Amidon GE, Amidon GL. 2014. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci. 57:152–163.
   PubMed Web of Science ®Google Scholar
• Vadher A, Parikh J, Parikh R, Solank AB. 2009. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac. AAPS PharmSciTech. 10(2):606–614.
   PubMed Web of Science ®Google Scholar
• USA. Food and Drug Administration. n.d. [accessed]. http://www.accessdata.fda.gov/scripts/cder/dissolution_dsp_getalldata,cfm
   Google Scholar
• Vincent J, Jasmine M, Delphine M. 2008. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 60(6):734–746.
   PubMed Web of Science ®Google Scholar
• Warkad S, Anantwar P, Bhusari M, Tale P, Pakhare V. 2019. Dissolution rate improvement of prasugrel hydrochloride by solid dispersion method using hpmc-as as a polymer. Int J Sci Res Rev. 8(4):355–376.
   Google Scholar